Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer.

por Venesmaa, P., Ylikorkala, O.
Publicado 1991

Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment.

por Aitokallio-Tallberg, A., Viinikka, L., Ylikorkala, O.
Publicado 1989

Effect of interleukin 2 on urinary excretion of degradation products of prostacyclin and thromboxane A2 in patients with ovarian cancer.

por Aitokallio-Tallberg, A., Lehtovirta, P., Vartiainen, J., Ylikorkala, O.
Publicado 1995

Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate.

por Aitokallio-Tallberg, A., Kärkkäinen, J., Pantzar, P., Wahlström, T., Ylikorkala, O.
Publicado 1985

Urinary epidermal growth factor concentrations in various human malignancies.

por Mattila, A. L., Saario, I., Viinikka, L., Ylikorkala, O., Perheentupa, J.
Publicado 1988

Human vascular endothelial cells produce TNF-α after stimulation with proinflammatory cytokines

por Ranta, V, Orpana, A, Carpén, O, Turpeinen, U, Ylikorkala , O, Viinikka, L
Publicado 1999

Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer.

por Venesmaa, P., Lehtovirta, P., Stenman, U. H., Leminen, A., Forss, M., Ylikorkala, O.
Publicado 1994

Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women

por Marttunen, M B, Cacciatore, B, Hietanen, P, Pyrhönen, S, Tiitinen, A, Wahlström, T, Ylikorkala, O
Publicado 2001

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy

por Goldstein, S. R., Bachmann, G. A., Koninckx, P. R., Lin, V. H., Portman, D. J., Ylikorkala, O.
Publicado 2014